Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2.

Détails

Ressource 1Télécharger: 37415560.pdf (775.19 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_ECDD80B202C8
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
UNIL/CHUV
Titre
Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2.
Périodique
Journal of the European Academy of Dermatology and Venereology
Auteur⸱e⸱s
Armstrong A., Eyerich K., Conrad C., Zhu Y., Yang Y.W., Miller M., You Y., Shen Y.K., Foley P., Griffiths CEM, Strober B.
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Statut éditorial
Publié
Date de publication
12/2023
Peer-reviewed
Oui
Volume
37
Numéro
12
Pages
e1375-e1379
Langue
anglais
Notes
Publication types: Letter
Publication Status: ppublish
Mots-clé
Humans, Antibodies, Monoclonal, Humanized/therapeutic use, Adalimumab, Psoriasis/drug therapy, Severity of Illness Index, Treatment Outcome, Double-Blind Method
URN
urn:nbn:ch:serval-BIB_ECDD80B202C83
OAI-PMH
oai:serval.unil.ch:BIB_ECDD80B202C8
DOI
10.1111/jdv.19309
Pubmed
37415560
Web of science
001038661400001
Open Access
Oui
Création de la notice
10/07/2023 13:49
Dernière modification de la notice
13/12/2023 7:26
Données d'usage